Janice Lamb
Pfizer (United States)(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Sexual function and dysfunction studies, Urinary Bladder and Prostate Research, Pulmonary Hypertension Research and Treatments, Neurological disorders and treatments
Most-Cited Works
- → Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation(2005)208 cited
- → Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease(2006)43 cited
- → A placebo‐controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK‐369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia(2010)42 cited
- → A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease(2007)31 cited
- → A placebo‐controlled exploratory study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK‐369,003 for the treatment of men with storage lower urinary tract symptoms associated with a clinical diagnosis of overactive bladder(2010)26 cited
- → Efficacy and tolerability of sumanirole in restless legs syndrome: A phase II, randomized, double-blind, placebo-controlled, dose–response study(2007)20 cited
- → Sudden large and periodic changes in heart rate in healthy young men after short periods of exercise.(1982)16 cited
- → Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa(2017)1 cited
- → Sitaxentan Improves Exercise Capacity In Treatment-Naive Adults With Functional Class III Pulmonary Arterial Hypertension(2012)
- → Client Presenting with Vaginismus(2012)